Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
783.18 | -49,6% | -28,91% | 705.179,49 | 0,68% | 2,63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
903.30 | -26,23% | -10,59% | 4.007.181,69 | 1,04% | 18,5% |
|
NYSE:JNJ
Johnson & Johnson
|
151.27 | 0% | 0% | 364.058,36 | 3,21% | 2,71% |
|
NYSE:MRK
Merck
|
130.99 | -9,88% | 3,33% | 331.772,3 | 2,35% | -19,03% |
|
NYSE:ABBV
AbbVie
|
164.56 | -22,18% | -11,89% | 290.591,2 | 3,73% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
120.96 | 19,03% | 41,77% | 187.516,43 | 2,01% | 15,98% |
|
NYSE:TMO
Thermo Fisher Scientific
|
594.01 | -17,25% | -7,97% | 226.743,31 | 0,26% | 14,15% |
|
SWX:ROG
Roche Holding
|
237.10 | 25,34% | 40,63% | 191.277,25 | 4,05% | 0,43% |
|
SWX:NOVN
Novartis
|
93.37 | 8,15% | 21,53% | 190.512,74 | 3,53% | 4,67% |
|
NYSE:DHR
Danaher
|
267.11 | -20,95% | -10,46% | 197.844,78 | 0,4% | 10,89% |
|
NYSE:ABT
Abbott Laboratories
|
103.21 | 3,3% | 16,15% | 179.547,6 | 2,11% | 9,04% |
|
NYSE:PFE
Pfizer
|
28.53 | 8,9% | 39,33% | 161.667,9 | 5,87% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
89.16 | 19,34% | 38,31% | 111.460,42 | 4,22% | 8,19% |
|
NYSE:MDT
Medtronic
|
84.51 | 26,22% | 39,29% | 112.214,28 | 3,21% | 2,09% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
987.27 | -29,95% | -23,98% | 106.512,12 | 0% | 13,9% |
|
LSE:GSK
GSK
|
17.75 | 7,44% | 23,26% | 72.385,16 | 3,27% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.36 | 64,24% | 74,73% | 87.895,06 | 5,45% | 13,54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.90 | 20,58% | 29,81% | 84.593,43 | 4,55% | 0,15% |
|
XTRA:MRK
Merck KGaA
|
166.55 | 3,34% | 18,14% | 72.412,26 | 1,32% | 10,73% |
|
NYSE:BDX
Becton Dickinson and Co
|
237.13 | 15,05% | 29,14% | 68.532,1 | 1,61% | 2,09% |
